PFG
DARE icon

Putney Financial Group’s Dare Bioscience DARE Stock Holding History

Putney Financial Group’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$2 – 128
2025
Q2 		$2 Hold
1
– – ﹤0.01% 293
2025
Q1 		$3 Hold
1
– – ﹤0.01% 280
2024
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 304

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putney Financial Group's DARE Position: Q3 2025 in Review

Putney Financial Group sold out of Dare Bioscience (DARE) in Q3 2025, closing a stake of 1 share — an estimated $2 sold.

Putney Financial Group first reported a position in DARE in Q4 2024 and held it in 3 quarters. The position peaked at $3 in Q1 2025. 21 funds tracked by Wall St. Rank hold DARE as of Q3 2025.

  • Putney Financial Group reported no remaining Dare Bioscience position as of Q3 2025 after selling out during the quarter.
  • Putney Financial Group sold 1 Dare Bioscience share in Q3 2025, an estimated $2.
  • Putney Financial Group first reported a position in Dare Bioscience in Q4 2024 and held it in 3 quarters.
  • Putney Financial Group's Dare Bioscience position peaked at $3 in Q1 2025.
  • 21 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2025.

Based on Putney Financial Group's 13F filing for Q3 2025, filed 7 Nov 2025.